Detection of FSH receptors in mouse and human penile tissue

Background: This study aims to investigate the expression of follicle-stimulating hormone (FSH) receptors in both mouse and human penis to explore its potential impact on penis function. Methods: We utilized immunohistochemistry to detect FSH receptors in penile and testicular tissues from 12 BALB/c mice, as well as penile tissues from three patients undergoing penectomy for squamous cell carcinoma. Results: Positive immunoreaction for FSH receptors was detected in tissue samples of all patients including sebaceous gland, epithelial layers, subepithelial fibroblasts, corpus cavernosum cells, walls of small blood vessels and plasma cells. However, species specificity was observed in the results, as positive immunoreaction was absent in the most of mouse penis tissue samples. Fibrocytes and mast cells in the mouse penis exhibited negligible positive immunoreaction. Conclusions: This study marks the first reported detection of FSH receptors in human penile tissue, highlighting a potential extragonadal role for FSH in penile function. While human tissues exhibited widespread receptor expression, mouse tissues showed minimal immunoreactivity, suggesting species-specific expression patterns. These preliminary findings indicate a possible regulatory role for FSH in human penile physiology, meriting further exploration in subsequent studies.

Follicle-stimulating hormone; Follicle-stimulating hormone receptor; Corpus cavernosum penis

[1] Holesh JE, Bass AN, Lord M. Physiology, ovulation. StatPearls Publishing: Treasure Island (FL). 2025.

[2] Rivero-Müller A, Huhtaniemi I. Genetic variants of gonadotrophins and their receptors: impact on the diagnosis and management of the infertile patient. Best Practice & Research Clinical Endocrinology & Metabolism. 2022; 36: 101596.

[3] Spaziani M, Carlomagno F, Tenuta M, Sesti F, Angelini F, Bonaventura I, et al. Extra-gonadal and non-canonical effects of FSH in males. Pharmaceuticals. 2023; 16: 813.

[4] Singh R, Kaur S, Yadav S, Bhatia S. Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome. Trends in Endocrinology & Metabolism. 2023; 34: 194–215.

[5] Morton AJ, Candelaria JI, McDonnell SP, Zgodzay DP, Denicol AC. Review: roles of follicle-stimulating hormone in preantral folliculogenesis of domestic animals: what can we learn from model species and where do we go from here? Animal. 2023; 17: 100743.

[6] Kaur M, Singh S, Kaur A. Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis. Journal of Ovarian Research. 2023; 16: 183.

[7] Bhartiya D, Patel H. An overview of FSH-FSHR biology and explaining the existing conundrums. Journal of Ovarian Research. 2021; 14: 144.

[8] Stilley JA, Christensen DE, Dahlem KB, Guan R, Santillan DA, England SK, et al. FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice. Biology of Reproduction. 2014; 91: 74.

[9] Starzyński D, Rzeszotek S, Kolasa A, Grabowska M, Wiszniewska B, Kudrymska A, et al. Pilot study: FSHR expression in neuroendocrine tumors of the appendix. Journal of Clinical Medicine. 2023; 12: 5086.

[10] Radu A, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. The New England Journal of Medicine. 2010; 363: 1621–1630.

[11] Robinson LJ, Tourkova I, Wang Y, Sharrow AC, Landau MS, Yaroslavskiy BB, et al. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochemical and Biophysical Research Communications. 2010; 394: 12–17.

[12] Ji Y, Liu P, Yuen T, Haider S, He J, Romero R, et al. Epitope-specific monoclonal antibodies to FSHβ increase bone mass. Proceedings of the National Academy of Sciences of the United States of America. 2018; 115: 2192–2197.

[13] Cui H, Zhao G, Liu R, Zheng M, Chen J, Wen J. FSH stimulates lipid biosynthesis in chicken adipose tissue by upregulating the expression of its receptor FSHR. Journal of Lipid Research. 2012; 53: 909–917.

[14] Liu P, Ji Y, Yuen T, Rendina-Ruedy E, DeMambro VE, Dhawan S, et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017; 546: 107–112.

[15] Xiong J, Tian Y, Ling A, Liu Z, Zhao L, Cheng G. Genistein affects gonadotrophin-releasing hormone secretion in GT1-7 cells via modulating kisspeptin receptor and key regulators. Systems Biology in Reproductive Medicine. 2022; 68: 138–150.

[16] Cheng Y, Zhu H, Ren J, Wu HY, Yu JE, Jin LY, et al. Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets. Nature Communications. 2023; 14: 6991.

[17] Ghinea N, Liehn EA, Grommes J, Delattre DD, Olesen TK. Follicle-stimulating hormone receptor expression in advanced atherosclerotic plaques. Scientific Reports. 2024; 14: 10176.

[18] Kokk K, Kuuslahti M, Keisala T, Purmonen S, Kaipia A, Tammela T, et al. Expression of luteinizing hormone receptors in the mouse penis. Journal of Andrology. 2011; 32: 49–54.

[19] Zirnask H, Pöllanen P, Suutre S, Kuuslahti M, Kotsar A, Pakarainen T, et al. Expression of LHCG receptors in the human penis. The Aging Male. 2018; 15: 8–13.

[20] Li L, Lin W, Wang Z, Huang R, Xia H, Li Z, et al. Hormone regulation in testicular development and function. International Journal of Molecular Sciences. 2024; 25: 5805.

[21] Rocca MS, Pannella M, Bayraktar E, Marino S, Bortolozzi M, Di Nisio A, et al. Extragonadal function of follicle-stimulating hormone: evidence for a role in endothelial physiology and dysfunction. Molecular and Cellular Endocrinology. 2024; 594: 112378.